ASPEN  PHARMACARE  HOLDINGS  LIMITED  (Incorporated  in  the  Republic  of  South  Africa)  Registration  number:    1985/0002935/06  Share  code:    APN  
ISIN:    ZAE000066692  
("Aspen"  or  "the  Company")  

PRE-­‐CLOSED PERIOD CONFERENCE CALL

The  Company  refers  to  the  disclosures  made  by  Aspen's  executive  directors  during  a  pre-­‐closed  period  conference  call  with  members  of  the  investment  community  on  27  June  2014  ("the  Conference  Call")  and  the  subsequent  SENS  announcement  dated  30  June  2014.  
Based  on  the  representations  made  by  the  Company  to  the  JSE,  as  well  as  the  relevant  facts  gathered  by  the  JSE  in  respect  of  this  matter,  the  JSE  has  informed  the  Company  that  it  did  not  find  any  breach  of  the  JSE's  Listings  Requirements  as  the  contents  of  the  Conference  Call  were  already  in  the  public  domain  and/or  were  not  materiality  price  sensitive  if  understood  in  its  context.    The  investigation  was  thus  closed  by  the  JSE.  

Durban  
1  September  2014  

Sponsor:

Investec  Bank  Limited              

distributed by